aluates Reports

$ 0.0

Automative

Global Rheumatology Arthritis Therapeutics Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-1J13864

Global Rheumatology Arthritis Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Rheumatology Arthritis Therapeutics Market Research Report 2025

Code: QYRE-Auto-1J13864

Report

April 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Boehringer Ingelheim GmbH

Novartis

Regeneron Pharmaceuticals Inc

Pfizer Inc

Bristol Myers Squibb Company

F Hoffmann La Roche Ltd

UCB

Johnson & Johnson Services Inc.

Amgen Inc

Rheumatology Arthritis Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rheumatology Arthritis Therapeutics Market

The global market for Rheumatology Arthritis Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Rheumatology Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatology Arthritis Therapeutics.

The Rheumatology Arthritis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rheumatology Arthritis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rheumatology Arthritis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Rheumatology Arthritis Therapeutics Market Report

Report Metric	Details
Report Name	Rheumatology Arthritis Therapeutics Market
CAGR	5%
Segment by Type	Topical Oral Parenteral
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Boehringer Ingelheim GmbH, Novartis AG, Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., UCB S.A., Johnson & Johnson Services, Inc., Amgen, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rheumatology Arthritis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rheumatology Arthritis Therapeutics Market report?

Ans: The main players in the Rheumatology Arthritis Therapeutics Market are AbbVie, Boehringer Ingelheim GmbH, Novartis AG, Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., UCB S.A., Johnson & Johnson Services, Inc., Amgen, Inc.

What are the Application segmentation covered in the Rheumatology Arthritis Therapeutics Market report?

Ans: The Applications covered in the Rheumatology Arthritis Therapeutics Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Rheumatology Arthritis Therapeutics Market report?

Ans: The Types covered in the Rheumatology Arthritis Therapeutics Market report are Topical, Oral, Parenteral

Recommended Reports

Autoimmune & Inflammatory

Pharmaceutical Services

Disease Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Rheumatology Arthritis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Topical

1.2.3 Oral

1.2.4 Parenteral

1.3 Market by Application

1.3.1 Global Rheumatology Arthritis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Rheumatology Arthritis Therapeutics Market Perspective (2020-2031)

2.2 Global Rheumatology Arthritis Therapeutics Growth Trends by Region

2.2.1 Global Rheumatology Arthritis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Rheumatology Arthritis Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Rheumatology Arthritis Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Rheumatology Arthritis Therapeutics Market Dynamics

2.3.1 Rheumatology Arthritis Therapeutics Industry Trends

2.3.2 Rheumatology Arthritis Therapeutics Market Drivers

2.3.3 Rheumatology Arthritis Therapeutics Market Challenges

2.3.4 Rheumatology Arthritis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Rheumatology Arthritis Therapeutics Players by Revenue

3.1.1 Global Top Rheumatology Arthritis Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Rheumatology Arthritis Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Rheumatology Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Rheumatology Arthritis Therapeutics Revenue

3.4 Global Rheumatology Arthritis Therapeutics Market Concentration Ratio

3.4.1 Global Rheumatology Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Rheumatology Arthritis Therapeutics Revenue in 2024

3.5 Global Key Players of Rheumatology Arthritis Therapeutics Head office and Area Served

3.6 Global Key Players of Rheumatology Arthritis Therapeutics, Product and Application

3.7 Global Key Players of Rheumatology Arthritis Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Rheumatology Arthritis Therapeutics Breakdown Data by Type

4.1 Global Rheumatology Arthritis Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Rheumatology Arthritis Therapeutics Forecasted Market Size by Type (2026-2031)

5 Rheumatology Arthritis Therapeutics Breakdown Data by Application

5.1 Global Rheumatology Arthritis Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Rheumatology Arthritis Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Rheumatology Arthritis Therapeutics Market Size (2020-2031)

6.2 North America Rheumatology Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Rheumatology Arthritis Therapeutics Market Size by Country (2020-2025)

6.4 North America Rheumatology Arthritis Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Rheumatology Arthritis Therapeutics Market Size (2020-2031)

7.2 Europe Rheumatology Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Rheumatology Arthritis Therapeutics Market Size by Country (2020-2025)

7.4 Europe Rheumatology Arthritis Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Rheumatology Arthritis Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Rheumatology Arthritis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Rheumatology Arthritis Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Rheumatology Arthritis Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Rheumatology Arthritis Therapeutics Market Size (2020-2031)

9.2 Latin America Rheumatology Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Rheumatology Arthritis Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Rheumatology Arthritis Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Rheumatology Arthritis Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Rheumatology Arthritis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Rheumatology Arthritis Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Rheumatology Arthritis Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Rheumatology Arthritis Therapeutics Introduction

11.1.4 AbbVie Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Boehringer Ingelheim GmbH

11.2.1 Boehringer Ingelheim GmbH Company Details

11.2.2 Boehringer Ingelheim GmbH Business Overview

11.2.3 Boehringer Ingelheim GmbH Rheumatology Arthritis Therapeutics Introduction

11.2.4 Boehringer Ingelheim GmbH Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025)

11.2.5 Boehringer Ingelheim GmbH Recent Development

11.3 Novartis AG

11.3.1 Novartis AG Company Details

11.3.2 Novartis AG Business Overview

11.3.3 Novartis AG Rheumatology Arthritis Therapeutics Introduction

11.3.4 Novartis AG Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025)

11.3.5 Novartis AG Recent Development

11.4 Regeneron Pharmaceuticals, Inc.

11.4.1 Regeneron Pharmaceuticals, Inc. Company Details

11.4.2 Regeneron Pharmaceuticals, Inc. Business Overview

11.4.3 Regeneron Pharmaceuticals, Inc. Rheumatology Arthritis Therapeutics Introduction

11.4.4 Regeneron Pharmaceuticals, Inc. Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025)

11.4.5 Regeneron Pharmaceuticals, Inc. Recent Development

11.5 Pfizer, Inc.

11.5.1 Pfizer, Inc. Company Details

11.5.2 Pfizer, Inc. Business Overview

11.5.3 Pfizer, Inc. Rheumatology Arthritis Therapeutics Introduction

11.5.4 Pfizer, Inc. Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025)

11.5.5 Pfizer, Inc. Recent Development

11.6 Bristol-Myers Squibb Company

11.6.1 Bristol-Myers Squibb Company Company Details

11.6.2 Bristol-Myers Squibb Company Business Overview

11.6.3 Bristol-Myers Squibb Company Rheumatology Arthritis Therapeutics Introduction

11.6.4 Bristol-Myers Squibb Company Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025)

11.6.5 Bristol-Myers Squibb Company Recent Development

11.7 F. Hoffmann-La Roche Ltd.

11.7.1 F. Hoffmann-La Roche Ltd. Company Details

11.7.2 F. Hoffmann-La Roche Ltd. Business Overview

11.7.3 F. Hoffmann-La Roche Ltd. Rheumatology Arthritis Therapeutics Introduction

11.7.4 F. Hoffmann-La Roche Ltd. Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025)

11.7.5 F. Hoffmann-La Roche Ltd. Recent Development

11.8 UCB S.A.

11.8.1 UCB S.A. Company Details

11.8.2 UCB S.A. Business Overview

11.8.3 UCB S.A. Rheumatology Arthritis Therapeutics Introduction

11.8.4 UCB S.A. Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025)

11.8.5 UCB S.A. Recent Development

11.9 Johnson & Johnson Services, Inc.

11.9.1 Johnson & Johnson Services, Inc. Company Details

11.9.2 Johnson & Johnson Services, Inc. Business Overview

11.9.3 Johnson & Johnson Services, Inc. Rheumatology Arthritis Therapeutics Introduction

11.9.4 Johnson & Johnson Services, Inc. Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025)

11.9.5 Johnson & Johnson Services, Inc. Recent Development

11.10 Amgen, Inc.

11.10.1 Amgen, Inc. Company Details

11.10.2 Amgen, Inc. Business Overview

11.10.3 Amgen, Inc. Rheumatology Arthritis Therapeutics Introduction

11.10.4 Amgen, Inc. Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025)

11.10.5 Amgen, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Boehringer Ingelheim GmbH

Novartis

Regeneron Pharmaceuticals Inc

Pfizer Inc

Bristol Myers Squibb Company

F Hoffmann La Roche Ltd

UCB

Johnson & Johnson Services Inc.

Amgen Inc

List of Tables

Table 1. Global Rheumatology Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Topical

Table 3. Key Players of Oral

Table 4. Key Players of Parenteral

Table 5. Global Rheumatology Arthritis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Rheumatology Arthritis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Rheumatology Arthritis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Rheumatology Arthritis Therapeutics Market Share by Region (2020-2025)

Table 9. Global Rheumatology Arthritis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Rheumatology Arthritis Therapeutics Market Share by Region (2026-2031)

Table 11. Rheumatology Arthritis Therapeutics Market Trends

Table 12. Rheumatology Arthritis Therapeutics Market Drivers

Table 13. Rheumatology Arthritis Therapeutics Market Challenges

Table 14. Rheumatology Arthritis Therapeutics Market Restraints

Table 15. Global Rheumatology Arthritis Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Rheumatology Arthritis Therapeutics Market Share by Players (2020-2025)

Table 17. Global Top Rheumatology Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Arthritis Therapeutics as of 2024)

Table 18. Ranking of Global Top Rheumatology Arthritis Therapeutics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Rheumatology Arthritis Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Rheumatology Arthritis Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Rheumatology Arthritis Therapeutics, Product and Application

Table 22. Global Key Players of Rheumatology Arthritis Therapeutics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Rheumatology Arthritis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Rheumatology Arthritis Therapeutics Revenue Market Share by Type (2020-2025)

Table 26. Global Rheumatology Arthritis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Rheumatology Arthritis Therapeutics Revenue Market Share by Type (2026-2031)

Table 28. Global Rheumatology Arthritis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Rheumatology Arthritis Therapeutics Revenue Market Share by Application (2020-2025)

Table 30. Global Rheumatology Arthritis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Rheumatology Arthritis Therapeutics Revenue Market Share by Application (2026-2031)

Table 32. North America Rheumatology Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Rheumatology Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Rheumatology Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Rheumatology Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Rheumatology Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Rheumatology Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Rheumatology Arthritis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Rheumatology Arthritis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Rheumatology Arthritis Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Rheumatology Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Rheumatology Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Rheumatology Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Rheumatology Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Rheumatology Arthritis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Rheumatology Arthritis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. AbbVie Company Details

Table 48. AbbVie Business Overview

Table 49. AbbVie Rheumatology Arthritis Therapeutics Product

Table 50. AbbVie Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 51. AbbVie Recent Development

Table 52. Boehringer Ingelheim GmbH Company Details

Table 53. Boehringer Ingelheim GmbH Business Overview

Table 54. Boehringer Ingelheim GmbH Rheumatology Arthritis Therapeutics Product

Table 55. Boehringer Ingelheim GmbH Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Boehringer Ingelheim GmbH Recent Development

Table 57. Novartis AG Company Details

Table 58. Novartis AG Business Overview

Table 59. Novartis AG Rheumatology Arthritis Therapeutics Product

Table 60. Novartis AG Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 61. Novartis AG Recent Development

Table 62. Regeneron Pharmaceuticals, Inc. Company Details

Table 63. Regeneron Pharmaceuticals, Inc. Business Overview

Table 64. Regeneron Pharmaceuticals, Inc. Rheumatology Arthritis Therapeutics Product

Table 65. Regeneron Pharmaceuticals, Inc. Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 66. Regeneron Pharmaceuticals, Inc. Recent Development

Table 67. Pfizer, Inc. Company Details

Table 68. Pfizer, Inc. Business Overview

Table 69. Pfizer, Inc. Rheumatology Arthritis Therapeutics Product

Table 70. Pfizer, Inc. Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 71. Pfizer, Inc. Recent Development

Table 72. Bristol-Myers Squibb Company Company Details

Table 73. Bristol-Myers Squibb Company Business Overview

Table 74. Bristol-Myers Squibb Company Rheumatology Arthritis Therapeutics Product

Table 75. Bristol-Myers Squibb Company Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 76. Bristol-Myers Squibb Company Recent Development

Table 77. F. Hoffmann-La Roche Ltd. Company Details

Table 78. F. Hoffmann-La Roche Ltd. Business Overview

Table 79. F. Hoffmann-La Roche Ltd. Rheumatology Arthritis Therapeutics Product

Table 80. F. Hoffmann-La Roche Ltd. Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 81. F. Hoffmann-La Roche Ltd. Recent Development

Table 82. UCB S.A. Company Details

Table 83. UCB S.A. Business Overview

Table 84. UCB S.A. Rheumatology Arthritis Therapeutics Product

Table 85. UCB S.A. Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 86. UCB S.A. Recent Development

Table 87. Johnson & Johnson Services, Inc. Company Details

Table 88. Johnson & Johnson Services, Inc. Business Overview

Table 89. Johnson & Johnson Services, Inc. Rheumatology Arthritis Therapeutics Product

Table 90. Johnson & Johnson Services, Inc. Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 91. Johnson & Johnson Services, Inc. Recent Development

Table 92. Amgen, Inc. Company Details

Table 93. Amgen, Inc. Business Overview

Table 94. Amgen, Inc. Rheumatology Arthritis Therapeutics Product

Table 95. Amgen, Inc. Revenue in Rheumatology Arthritis Therapeutics Business (2020-2025) & (US$ Million)

Table 96. Amgen, Inc. Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Rheumatology Arthritis Therapeutics Picture

Figure 2. Global Rheumatology Arthritis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Rheumatology Arthritis Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Topical Features

Figure 5. Oral Features

Figure 6. Parenteral Features

Figure 7. Global Rheumatology Arthritis Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Rheumatology Arthritis Therapeutics Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Rheumatology Arthritis Therapeutics Report Years Considered

Figure 13. Global Rheumatology Arthritis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Rheumatology Arthritis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Rheumatology Arthritis Therapeutics Market Share by Region: 2024 VS 2031

Figure 16. Global Rheumatology Arthritis Therapeutics Market Share by Players in 2024

Figure 17. Global Top Rheumatology Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Arthritis Therapeutics as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Rheumatology Arthritis Therapeutics Revenue in 2024

Figure 19. North America Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Rheumatology Arthritis Therapeutics Market Share by Country (2020-2031)

Figure 21. United States Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Rheumatology Arthritis Therapeutics Market Share by Country (2020-2031)

Figure 25. Germany Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Rheumatology Arthritis Therapeutics Market Share by Region (2020-2031)

Figure 33. China Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Rheumatology Arthritis Therapeutics Market Share by Country (2020-2031)

Figure 41. Mexico Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Rheumatology Arthritis Therapeutics Market Share by Country (2020-2031)

Figure 45. Turkey Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Rheumatology Arthritis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. AbbVie Revenue Growth Rate in Rheumatology Arthritis Therapeutics Business (2020-2025)

Figure 49. Boehringer Ingelheim GmbH Revenue Growth Rate in Rheumatology Arthritis Therapeutics Business (2020-2025)

Figure 50. Novartis AG Revenue Growth Rate in Rheumatology Arthritis Therapeutics Business (2020-2025)

Figure 51. Regeneron Pharmaceuticals, Inc. Revenue Growth Rate in Rheumatology Arthritis Therapeutics Business (2020-2025)

Figure 52. Pfizer, Inc. Revenue Growth Rate in Rheumatology Arthritis Therapeutics Business (2020-2025)

Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Rheumatology Arthritis Therapeutics Business (2020-2025)

Figure 54. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Rheumatology Arthritis Therapeutics Business (2020-2025)

Figure 55. UCB S.A. Revenue Growth Rate in Rheumatology Arthritis Therapeutics Business (2020-2025)

Figure 56. Johnson & Johnson Services, Inc. Revenue Growth Rate in Rheumatology Arthritis Therapeutics Business (2020-2025)

Figure 57. Amgen, Inc. Revenue Growth Rate in Rheumatology Arthritis Therapeutics Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Rheumatology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Psoriatic Arthritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Autoimmune Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Musculoskeletal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Autoimmune Diseases Treatment Market Research Report 2024

Pharmaceuticals and Biotechnology R D Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025

Ankle Arthritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatic Heart Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rabies Treatment Market Research Report 2024

Global Still s Disease Treatment Market Research Report 2025

Global Musculoskeletal Disorders Therapeutics Market Research Report 2025

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Osteoarthritis Pain Solution Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20Y6853

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Regenerative Therapies for Osteoarthritis Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36Y13907

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Rheumatoid Arthritis Diagnosis Tests Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19O6132

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Psoriatic Arthritis Therapeutics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9A6304

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions